Mortality Rates from Asbestos-related Diseases in Italy During the First Year of the COVID-19 Pandemic

Overview

Journal Front Public Health

Specialty Public Health

Date 2024 Jan 31

PMID 38292377

Authors

Lucia Fazzo

Enrico Grande

Amerigo Zona

Giada Minelli

Roberta Crialesi

Ivano Iavarone

Francesco Grippo

Affiliations

Soon will be listed here.

Abstract

Background And Aim: Patients with interstitial lung diseases, including asbestosis, showed high susceptibility to the SARS-CoV-2 virus and a high risk of severe COVID-19 symptoms. Italy, highly impacted by asbestos-related diseases, in 2020 was among the European countries with the highest number of COVID-19 cases. The mortality related to malignant mesotheliomas and asbestosis in 2020 and its relationship with COVID-19 in Italy are investigated.

Methods: All death certificates involving malignant mesotheliomas or asbestosis in 2010-2020 and those involving COVID-19 in 2020 were retrieved from the National Registry of Causes of Death. Annual mortality rates and rate ratios (RRs) of 2020 and 2010-2014 compared to 2015-2019 were calculated. The association between malignant pleural mesothelioma (MPM) and asbestosis with COVID-19 in deceased adults ≥80 years old was evaluated through a logistic regression analysis (odds ratios: ORs), using MPM and asbestosis deaths COVID-19-free as the reference group. The hospitalization for asbestosis in 2010-2020, based on National Hospital Discharge Database, was analyzed.

Results: In 2020, 746,343 people died; out of them, 1,348 involved MPM and 286 involved asbestosis. Compared to the period 2015-2019, the mortality involving the two diseases decreased in age groups below 80 years; meanwhile, an increasing trend was observed in subjects aged 80 years and older, with a relative mortality risks of 1.10 for MPM and 1.17 for asbestosis. In subjects aged ≥80 years, deaths with COVID-19 were less likely to have MPM in both genders (men: OR = 0.22; women: OR = 0.44), while no departure was observed for asbestosis. A decrease in hospitalization in 2020 with respect to those in 2010-2019 in all age groups, both considering asbestosis as the primary or secondary diagnosis, was observed.

Conclusions: The increasing mortality involving asbestosis and, even if of slight entity, MPM, observed in people aged over 80 years during the 1 year of the COVID-19 pandemic, aligned in part with the previous temporal trend, could be due to several factors. Although no positive association with COVID-19 mortality was observed, the decrease in hospitalizations for asbestosis among individuals aged over 80 years, coupled with the increase in deaths, highlights the importance of enhancing home-based assistance during the pandemic periods for vulnerable patients with asbestos-related conditions.

References

Kokturk N, Babayigit C, Kul S, Duru Cetinkaya P, Nayci S, Argun Baris S . The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients. Respir Med. 2021; 183:106433. PMC: 8079263. DOI: 10.1016/j.rmed.2021.106433. View

Fazzo L, Binazzi A, Ferrante D, Minelli G, Consonni D, Bauleo L . Burden of Mortality from Asbestos-Related Diseases in Italy. Int J Environ Res Public Health. 2021; 18(19). PMC: 8508095. DOI: 10.3390/ijerph181910012. View

Whisenant J, Baena J, Cortellini A, Huang L, Lo Russo G, Porcu L . A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry. J Thorac Oncol. 2022; 17(5):661-674. PMC: 8804493. DOI: 10.1016/j.jtho.2021.12.015. View

Rugge M, Zorzi M, Guzzinati S . SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer. Nat Cancer. 2022; 1(8):784-788. DOI: 10.1038/s43018-020-0104-9. View

Mangone L, Mancuso P, Bisceglia I, Rossi P, Chellini E, Negro C . The impact of COVID-19 on new mesothelioma diagnoses in Italy. Thorac Cancer. 2022; 13(5):702-707. PMC: 8888152. DOI: 10.1111/1759-7714.14296. View

Dorrucci M, Minelli G, Boros S, Manno V, Prati S, Battaglini M . Excess Mortality in Italy During the COVID-19 Pandemic: Assessing the Differences Between the First and the Second Wave, Year 2020. Front Public Health. 2021; 9:669209. PMC: 8322580. DOI: 10.3389/fpubh.2021.669209. View

Grande E, Fedeli U, Pappagallo M, Crialesi R, Marchetti S, Minelli G . Variation in Cause-Specific Mortality Rates in Italy during the First Wave of the COVID-19 Pandemic: A Study Based on Nationwide Data. Int J Environ Res Public Health. 2022; 19(2). PMC: 8776013. DOI: 10.3390/ijerph19020805. View

Fazzo L, Minelli G, De Santis M, Ceccarelli E, Iavarone I, Zona A . The Epidemiological Surveillance of Mesothelioma Mortality in Italy as a Tool for the Prevention of Asbestos Exposure. Int J Environ Res Public Health. 2023; 20(11). PMC: 10252364. DOI: 10.3390/ijerph20115957. View

Serraino D, Zucchetto A, Dal Maso L, Del Zotto S, Taboga F, Clagnan E . Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy. Cancer Med. 2021; 10(21):7781-7792. PMC: 8559499. DOI: 10.1002/cam4.4271. View

10.

Azadeh N, Limper A, Carmona E, Ryu J . The Role of Infection in Interstitial Lung Diseases: A Review. Chest. 2017; 152(4):842-852. PMC: 7094545. DOI: 10.1016/j.chest.2017.03.033. View

11.

Aveyard P, Gao M, Lindson N, Hartmann-Boyce J, Watkinson P, Young D . Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021; 9(8):909-923. PMC: 8016404. DOI: 10.1016/S2213-2600(21)00095-3. View

12.

Riccardo F, Ajelli M, Andrianou X, Bella A, Del Manso M, Fabiani M . Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020. Euro Surveill. 2020; 25(49). PMC: 7730489. DOI: 10.2807/1560-7917.ES.2020.25.49.2000790. View

13.

Michelozzi P, deDonato F, Scortichini M, De Sario M, Noccioli F, Rossi P . Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020. Euro Surveill. 2020; 25(19). PMC: 7238743. DOI: 10.2807/1560-7917.ES.2020.25.19.2000620. View

14.

Ciminelli G, Garcia-Mandico S . COVID-19 in Italy: An Analysis of Death Registry Data. J Public Health (Oxf). 2020; 42(4):723-730. PMC: 7543414. DOI: 10.1093/pubmed/fdaa165. View

15.

Luo J, Rizvi H, Preeshagul I, Egger J, Hoyos D, Bandlamudi C . COVID-19 in patients with lung cancer. Ann Oncol. 2020; 31(10):1386-1396. PMC: 7297689. DOI: 10.1016/j.annonc.2020.06.007. View

16.

Ouyang L, Gong J, Yu M . Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis. Int Immunopharmacol. 2021; 100:108145. PMC: 8450148. DOI: 10.1016/j.intimp.2021.108145. View

17.

Haineala B, Zgura A, Badiu D, Iliescu L, Anghel R, Bacinschi X . Lung Cancer, Covid-19 Infections and Chemotherapy. In Vivo. 2021; 35(3):1877-1880. PMC: 8193347. DOI: 10.21873/invivo.12450. View

18.

Ceccarelli E, Minelli G, Egidi V, Lasinio G . Assessment of Excess Mortality in Italy in 2020-2021 as a Function of Selected Macro-Factors. Int J Environ Res Public Health. 2023; 20(4). PMC: 9956038. DOI: 10.3390/ijerph20042812. View

19.

Grippo F, Grande E, Maraschini A, Navarra S, Pappagallo M, Marchetti S . Evolution of Pathology Patterns in Persons Who Died From COVID-19 in Italy: A National Study Based on Death Certificates. Front Med (Lausanne). 2021; 8:645543. PMC: 8019728. DOI: 10.3389/fmed.2021.645543. View

20.

Vahabi N, Salehi M, Duarte J, Mollalo A, Michailidis G . County-level longitudinal clustering of COVID-19 mortality to incidence ratio in the United States. Sci Rep. 2021; 11(1):3088. PMC: 7862666. DOI: 10.1038/s41598-021-82384-0. View